Skip to content

Clinical trials

Recruiting Phase 1/2 Esophageal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1/2 Status: Recruiting Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20182
20191
20212
20237
20246
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Cancer Research UK2
Essen Biotech2
Anhui Provincial Hospital1
Arvinas Inc.1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Centre Hospitalier Universitaire de Besancon1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Chongqing Precision Biotech Co., Ltd1
Lantheus Medical Imaging1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms32
Stomach Neoplasms20
Colorectal Neoplasms14
Pancreatic Neoplasms12
Ovarian Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Uterine Cervical Neoplasms9
Lung Neoplasms8
Head and Neck Neoplasms7
Breast Neoplasms6

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.